Clinical Trials

Pharmaxis has conducted a number of clinical trials as part of the regulatory approvals process for Bronchitol.

Cystic Fibrosis

Phase IV
Description Five Year Post Authorisation Safety Study of Bronchitol (Inhaled Mannitol) in the UK
Sites UK Patient Registry
Subjects 1,349
Status Complete
More Information
Media Releases
Phase III
Description CF303: Treatment of adults with Cystic Fibrosis
Sites 126 Sites in Europe , Australia, Middle East, New Zealand, North America, Russia, South Africa, South America
Subjects 423
Status Complete
More Information


Media Releases is a service provided by the U.S. National Institutes of Health, Department of Health and Human Services, through its National Library of Medicine. provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions. Pharmaxis chooses to publish all Pivotal Trials on the website.

** Pubmed is a service of the U.S. National Library of Medicine and the National Institutes of Health.

*** No further clinical development planned in Bronchiectasis